AVITA Medical Inc
Research AVITA Medical Inc (RCEL) on Bullrun: market cap USD 324.73M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerRCEL
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryMedical Devices
- CurrencyUSD
- Market capUSD 324.73M
- Financial periodQ2 2026
- RevenueUSD 21.70M
- Net income-USD 7.66M
- Free cash flow-USD 3.61M
- Gross margin81.9%
Valuation Snapshot
latest market cap is USD 324.73M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 71.61M | -USD 48.59M | -USD 32.20M | 82.1% | -1.74 | USD 10.24M | USD 42.98M | -USD 16.65M |
| FY2024 | USD 64.25M | -USD 61.85M | -USD 58.11M | 85.8% | -2.39 | USD 14.05M | USD 42.25M | USD 4.50M |
| FY2023 | USD 50.14M | -USD 35.38M | -USD 39.39M | 84.5% | -1.4 | USD 22.12M | USD 39.81M | USD 49.06M |
| FY2022 | USD 34.42M | -USD 26.67M | -USD 19.54M | 82.4% | 1.07 | USD 18.16M | USD 532.00K | USD 84.74M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 324.73M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 105.47M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 337.33M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 350.56M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 165.20M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 298.61M | n/a | n/a | n/a |
About AVITA Medical Inc
AVITA Medical, Inc., together with its subsidiaries, operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds and full-thickness skin defects, as well as for repigmentation of stable depigmented vitiligo lesions. It also provides RECALL autologous cell harvesting device, which can treat areas of up to 1,920 cm2;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is AVITA Medical Inc's market cap?
AVITA Medical Inc's market capitalization is USD 324.73M.
What does AVITA Medical Inc do?
AVITA Medical, Inc., together with its subsidiaries, operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds and full-thickness skin defects, as well as for repigmentation of stable depigmented vitiligo lesions.